PET concerns in bevacizumab treatment (multiple letters)

Carsten Goessl; Zarko Grozdanovic; Christopher G. Willett; Daniel Duda; Alan Fischman; Rakesh K. Jain

doi:10.1038/nm0604-561a

PET concerns in bevacizumab treatment (multiple letters)

Carsten Goessl, Zarko Grozdanovic, Christopher G. Willett, Daniel Duda, Alan Fischman, Rakesh K. Jain

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	561
Number of pages	1
Journal	Nature Medicine
Volume	10
Issue number	6
DOIs	https://doi.org/10.1038/nm0604-561a
State	Published - Jun 2004

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/nm0604-561a

Cite this

@article{63a8be8657384c07b385b0c90ce91de9,

title = "PET concerns in bevacizumab treatment (multiple letters)",

author = "Carsten Goessl and Zarko Grozdanovic and Willett, \{Christopher G.\} and Daniel Duda and Alan Fischman and Jain, \{Rakesh K.\}",

year = "2004",

month = jun,

doi = "10.1038/nm0604-561a",

language = "English (US)",

volume = "10",

pages = "561",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "6",

}

TY - JOUR

T1 - PET concerns in bevacizumab treatment (multiple letters)

AU - Goessl, Carsten

AU - Grozdanovic, Zarko

AU - Willett, Christopher G.

AU - Duda, Daniel

AU - Fischman, Alan

AU - Jain, Rakesh K.

PY - 2004/6

Y1 - 2004/6

UR - https://www.scopus.com/pages/publications/2942705791

UR - https://www.scopus.com/inward/citedby.url?scp=2942705791&partnerID=8YFLogxK

U2 - 10.1038/nm0604-561a

DO - 10.1038/nm0604-561a

M3 - Letter

C2 - 15170192

AN - SCOPUS:2942705791

SN - 1078-8956

VL - 10

SP - 561

JO - Nature Medicine

JF - Nature Medicine

IS - 6

ER -

PET concerns in bevacizumab treatment (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this